Engleman Edgar's Form 4 filing
Bolt Biotherapeutics, Inc. (BOLT) · filed Dec 1, 2023
- Accession no.
- 0001209191-23-057049
- Filed
- Dec 1, 2023
- Trade date
- Nov 29-30, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $129.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Engleman EdgarCIK 0001227162 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | SSaleDisposed | −22,674 | $0.91 | −$20,633.34 | 1,929,628 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −108,145 | $0.86 | −$93,004.7 | 1,821,483 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −3,131 | $0.91 | −$2,849.21 | 266,456 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −14,934 | $0.86 | −$12,843.24 | 251,522 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.